LVD Biotech iVascular angiolite sirolimus eluting coronary stent system - HSA Registration DE0502735
Access comprehensive regulatory information for LVD Biotech iVascular angiolite sirolimus eluting coronary stent system in the Singapore medical device market through Pure Global AI's free database. This CLASS COM medical device is registered under HSA registration number DE0502735 and owned by LIFE VASCULAR DEVICES BIOTECH, S.L.. The device was registered on January 30, 2019.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The LVD Biotech iVascular angiolite sirolimus eluting coronary stent system is indicated for increasing the internal diameter of an artery with the aim of improving blood flow in the following cases: Patients with symptomatic ischemic heart disease due to โde novoโ stenotic and re-stenotic lesions located in arteries with diameters from 2 mm to 4.5 mm; Patients with occlusive disease due to acute myocardial infarction located in arteries with diameters from 2 mm to 4.5 mm.

